Coronary Flow Reserve Impairment in Apical vs Asymmetrical Septal Hypertrophic Cardiomyopathy

被引:16
|
作者
Ahn, Hyo-Suk [1 ]
Kim, Hyung-Kwan [1 ,2 ]
Park, Eun-Ah [3 ]
Lee, Whal [3 ]
Kim, Yong-Jin [1 ,2 ]
Cho, Goo-Yeong [1 ,2 ]
Park, Jae-Hyung [3 ]
Sohn, Dae-Won [1 ,2 ]
机构
[1] Seoul Natl Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Cardiovasc Ctr, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul 110744, South Korea
基金
新加坡国家研究基金会;
关键词
TRANSTHORACIC DOPPLER-ECHOCARDIOGRAPHY; VENTRICULAR FILLING PRESSURES; BLOOD-FLOW; VASODILATOR RESERVE; VELOCITY; ARTERY; CIRCULATION; TOMOGRAPHY;
D O I
10.1002/clc.22095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mechanisms underlying a reduction in coronary flow reserve (CFR) in hypertrophic cardiomyopathy (HCM), especially apical HCM (ApHCM), are elusive. This study set out to evaluate mechanisms underlying a reduction in CFR in 2 HCM subtypes. Hypothesis Mechanisms for CFR reduction in HCM are different between the 2 subtypes of HCM. Methods Thirty-one patients with asymmetrical septal hypertrophy (ASH), 43 with ApHCM, and 27 healthy volunteers were recruited. Mean diastolic coronary flow velocity (CFmv) was monitored before and after adenosine infusion by transthoracic echocardiography in the mid-to-distal left anterior descending coronary artery. Coronary flow reserve was defined as the ratio between CFmv before and after adenosine infusion. Left ventricular mass index and stress myocardial perfusion were assessed by cardiac magnetic resonance imaging. Results Although basal CFmv was higher in ASH patients than in healthy controls (P < 0.05), it was similar in ApHCM patients and controls (P = 0.85). Poststress CFmv was significantly lower in both HCM subtypes than in controls (P < 0.05). Consequently, CFR was higher in controls than in ASH or ApHCM patients (P < 0.05). When HCM patients were stratified into 2 groups based on the presence of CFR impairment, no difference was observed between these 2 groups in terms of left ventricular mass index by cardiac magnetic resonance imaging. Multivariate logistic regression analysis identified basal CFmv as the only independent variable associated with CFR reduction in HCM (r2 = 0.49, P < 0.001). Conclusions Whereas the inability to augment coronary flow to its maximal level during stress was found to underlie CFR impairment in both HCM subtypes, the recruitment of vasodilatory capacity at baseline was more prominent in ASH than in ApHCM patients. This study was presented in the Annual Scientific Meeting of the American Society of Echocardiography, June 30July 3, 2012, National Harbor, Maryland. This research was supported by Handok Research Fund 2012 and by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (0640-20100001). The authors have no other funding, financial relationships, or conflicts of interest to disclose.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 50 条
  • [41] Prognostic significance of coronary flow reserve assessed by MR flow measurement in the coronary sinus in patients with hypertrophic cardiomyopathy
    Yasuyuki Shiraishi
    Tatsuro Ito
    Masaki Ishida
    Motonori Nagata
    Kakuya Kitagawa
    Hiroshi Nakajima
    Kaoru Dohi
    Masaaki Ito
    Hajime Sakuma
    Journal of Cardiovascular Magnetic Resonance, 15 (Suppl 1)
  • [42] MR measurement of coronary blood flow and vasodilator flow reserve in 29 patients with hypertrophic cardiomyopathy
    Kawada, N
    Sakuma, H
    Yamakado, T
    Isaka, N
    Nakano, T
    Higgins, CB
    Takeda, K
    CIRCULATION, 1998, 98 (17) : 372 - 372
  • [43] Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: A myocardial PET study
    Feola, Mauro
    Chauvie, Stephane
    Rosso, Gian Luca
    Biggi, Alberto
    Ribichini, Flavio
    Bobbio, Marco
    JOURNAL OF NUCLEAR CARDIOLOGY, 2008, 15 (06) : 811 - 817
  • [44] Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: A myocardial PET study
    Feola M.
    Chauvie S.
    Rosso G.L.
    Biggi A.
    Ribichini F.
    Bobbio M.
    Journal of Nuclear Cardiology, 2008, 15 (6) : 811 - 817
  • [45] CORONARY FLOW RESERVE MEASUREMENT ALLOWS DIFFERENTIATION OF HYPERTROPHIC CARDIOMYOPATHY FROM THE ATHLETES HEART
    CHOUDHURY, L
    RADVAN, J
    SHERIDAN, DJ
    OAKLEY, CM
    CAMICI, PG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A160 - A160
  • [46] Coronary flow velocity reserve differs between patients with hypertrophic cardiomyopathy and systemic hypertension
    Frimm, CD
    Pereira, VF
    Rodrigues, ACT
    Tsutsui, JM
    Cúri, M
    Matsumoto, AY
    Arteaga, E
    Mady, C
    CIRCULATION, 2001, 104 (17) : 756 - 756
  • [47] Dual assessment of coronary flow reserve in non obstructive hypertrophic cardiomyopathy: patophysiological characteristics
    Tesic, M.
    Djordjevic-Dikic, A.
    Trifunovic, D.
    Petrovic, O.
    Nedeljkovic, I.
    Petrovic, M.
    Giga, V.
    Stankovic, G.
    Beleslin, B.
    Vujisic-Tesic, B.
    EUROPEAN HEART JOURNAL, 2012, 33 : 741 - 741
  • [48] Apical infarct via septal collateralization complicating transluminal alcohol septal ablation for hypertrophic cardiomyopathy
    Parham, WA
    Kern, MJ
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 60 (02) : 208 - 211
  • [49] Changes in phasic coronary blood flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy
    Kyriakidis, MK
    Dernellis, JM
    Androulakis, AE
    Kelepeshis, GA
    Barbetseas, J
    Anastasakis, AN
    Trikas, AG
    Tentolouris, CA
    Gialafos, JE
    Toutouzas, PK
    CIRCULATION, 1997, 96 (03) : 834 - 841
  • [50] Changes in phasic coronary blood flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy
    Kyriakidis, M
    Dernellis, J
    Kelepesis, G
    Barbetseas, J
    Androulakis, A
    Gialafos, J
    Toutouzas, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 6272 - 6272